PMID- 11810048 OWN - NLM STAT- MEDLINE DCOM- 20020307 LR - 20180213 IS - 0030-2414 (Print) IS - 0030-2414 (Linking) VI - 62 IP - 1 DP - 2002 TI - Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma. PG - 85-93 AB - The study was conducted to clarify the cytocidal effect of combination therapy consisting of administration of acridine orange (AO), which is a photosensitizer, and radiation therapy using in vitro and in vivo mouse osteosarcoma models. The results revealed that AO combined with low-dose X-ray irradiation of about 1-5 Gy had a strong cytocidal effect on the cultured mouse osteosarcoma cells regardless of their chemosensitivity, and that this combination therapy inhibited growth of the in vivo mouse osteosarcoma by induction of tumor necrosis. This effect was inhibited by L-histidine, but not by mannitol. These findings suggested that AO might be excited by X-rays and kill osteosarcoma cells through the release of singlet oxygen, which is toxic to living cells. This mechanism is similar to that of photodynamic therapy with AO. CI - Copyright 2002 S. Karger AG, Basel FAU - Hashiguchi, Shin AU - Hashiguchi S AD - Department of Orthopedic Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan. FAU - Kusuzaki, Katsuyuki AU - Kusuzaki K FAU - Murata, Hiroaki AU - Murata H FAU - Takeshita, Hideyuki AU - Takeshita H FAU - Hashiba, Mitsuoki AU - Hashiba M FAU - Nishimura, Tsunehiko AU - Nishimura T FAU - Ashihara, Tsukasa AU - Ashihara T FAU - Hirasawa, Yasusuke AU - Hirasawa Y LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Switzerland TA - Oncology JT - Oncology JID - 0135054 RN - F30N4O6XVV (Acridine Orange) SB - IM MH - Acridine Orange/adverse effects/*radiation effects/*therapeutic use MH - Animals MH - Cell Size/drug effects/radiation effects MH - Cell Survival/drug effects/radiation effects MH - Dose-Response Relationship, Radiation MH - Lung Neoplasms/drug therapy/pathology/radiotherapy/secondary MH - Mice MH - Microscopy, Fluorescence MH - Neoplasm Transplantation MH - Osteosarcoma/*drug therapy/pathology/*radiotherapy MH - Photochemotherapy/*methods MH - Survival Rate MH - Time Factors MH - Tumor Cells, Cultured MH - X-Rays EDAT- 2002/01/26 10:00 MHDA- 2002/03/08 10:01 CRDT- 2002/01/26 10:00 PHST- 2002/01/26 10:00 [pubmed] PHST- 2002/03/08 10:01 [medline] PHST- 2002/01/26 10:00 [entrez] AID - ocl62085 [pii] AID - 10.1159/000048251 [doi] PST - ppublish SO - Oncology. 2002;62(1):85-93. doi: 10.1159/000048251.